ReviewRSC advances2025
Bimetallic and multimetallic nanozymes: synergistic catalysis for advanced biomedical and health applications.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A colorimetric sensor array based on merging silver nanozymes and gold nanoparticles for chronic kidney disease diagnosis and post-transplant monitoring.RSC advances · 2026Article
- Gold-Dispersed Copper Ferrite Magnetic Hydrogel: A Potent Antibacterial Nanozyme Platform.Gels (Basel, Switzerland) · 2026Article
- Research progress in immobilized nanozymes based on hybrid nanoflowers, MOFs and nanogels.Mikrochimica acta · 2026Review
- Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology.Micromachines · 2026Review
- The Current Application Prospects of Nanomedicine in Renal Ischemia-Reperfusion Injury.International journal of nanomedicine · 2026Review
- Nanozyme-Driven Ferroptosis-Cuproptosis Interplay in Lung Cancer.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanozymes are a class of nanomaterials with enzyme-mimetic catalytic activities. Owing to their high stability, tunable catalytic performance, and ease of preparation, they have emerged as important alternatives to natural enzymes. However, single-metal nanozymes often face challenges such as insufficient active sites, low catalytic efficiency, and limited functionality. The introduction of a second or multiple metals into nanozymes significantly boosts their catalytic efficiency and multifunctionality through intermetallic electronic coupling and synergy. This review systematically summarizes the latest research progress on nanozymes composed of Fe, Mn, Cu, Pt, Au, Pd, Ga, Mo, Ni, and multi-metallic systems. It focuses on their applications in therapeutic interventions and health monitoring strategies, which encompass not only highly sensitive biosensing for disease biomarkers but also the detection and degradation of environmental pollutants that pose significant risks to human health. Finally, we outline key challenges and future prospects in critical areas ranging from atomically-precise synthesis and mechanistic studies to the development of smart systems and clinical translation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.